1. Home
  2. SHIM vs NORD Comparison

SHIM vs NORD Comparison

Compare SHIM & NORD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

N/A

Current Price

$3.24

Market Cap

95.9M

Sector

N/A

ML Signal

N/A

NORD

Nordicus Partners Corporation Common Stock

N/A

Current Price

$2.85

Market Cap

95.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
SHIM
NORD
Founded
1990
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
95.9M
95.5M
IPO Year
2023
2005

Fundamental Metrics

Financial Performance
Metric
SHIM
NORD
Price
$3.24
$2.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
★ 60.6K
15.7K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.95
31.25
EPS
N/A
★ N/A
Revenue
★ $492,844,000.00
$3,346.00
Revenue This Year
$1.41
N/A
Revenue Next Year
$20.36
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 2.63
N/A
52 Week Low
$2.01
$2.70
52 Week High
$6.76
$5.28

Technical Indicators

Market Signals
Indicator
SHIM
NORD
Relative Strength Index (RSI) 65.29 18.64
Support Level $2.89 N/A
Resistance Level $4.08 $3.52
Average True Range (ATR) 0.21 0.57
MACD 0.07 -0.19
Stochastic Oscillator 91.40 12.05

Price Performance

Historical Comparison
SHIM
NORD

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About NORD Nordicus Partners Corporation Common Stock

Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.

Share on Social Networks: